How Oxandrolone Affects HDL Cholesterol
Oxandrolone (Anavar) suppresses HDL via the same 17-alpha-alkylated hepatic lipase mechanism as stanozolol, but with moderate rather than severe effect. Despite its reputation as a 'mild' oral, oxandrolone is not lipid-neutral and produces clinically significant HDL reduction at bodybuilding doses.
The Mechanism
Oxandrolone suppresses HDL through the same mechanistic pathway as other 17-alpha-alkylated oral steroids, though with less potency per milligram:
- Hepatic lipase (HTGL) upregulation via first-pass metabolism: As a 17-AA oral, oxandrolone survives first-pass liver metabolism and delivers an androgenic signal to hepatocytes that upregulates HTGL, accelerating HDL catabolism.
- ApoA-I reduction: Like other orals, oxandrolone reduces ApoA-I production, impairing de novo HDL synthesis.
- No aromatisation: Oxandrolone does not aromatise to estradiol, removing the estrogenic HDL-protective counterbalance. However, the overall androgenic potency of oxandrolone is more moderate than stanozolol, producing a less extreme HTGL surge.
- Relative mitigation vs. other orals: Oxandrolone's milder androgenic potency results in less HTGL stimulation than stanozolol at equivalent milligram doses. This is why it is often described as "milder," but milder is not the same as neutral.
Expected Changes
At 10-20 mg/day (clinical and lower bodybuilding doses):
- Moderate HDL suppression, typically 20-40% from baseline
- A pre-cycle HDL of 50 mg/dL might fall to 30-40 mg/dL
At 24 mg/day (documented in clinical literature):
- HDL has been documented falling to 24 mg/dL in controlled settings
- Recovery to 49 mg/dL was observed within 3 months of cessation
At 40-80 mg/day (common bodybuilding doses):
- Significant suppression expected (30-50%+)
- The "mild" reputation often reflects low-dose comparisons; at high bodybuilding doses, oxandrolone's lipid impact becomes substantial
Recovery: Relatively faster than with stanozolol. HDL typically recovers to near-baseline within 2-3 months of stopping oxandrolone.
Monitoring Guidance
Baseline lipid panel before starting:
- Know your pre-cycle HDL to accurately quantify the degree of suppression
On cycle:
- Check lipids at week 4 of a typical 6-8 week cycle
- If HDL has fallen below 25 mg/dL, consider dose reduction or cycle shortening
Post-cycle:
- Recheck at 6-8 weeks after stopping. Recovery is generally faster than with stanozolol or trenbolone.
Management Strategies
During cycle:
- Keep doses moderate (10-20 mg/day if possible); dose-response relationship is significant
- Avoid stacking with other 17-alpha-alkylated orals; the hepatic load and lipid effects are additive
- Cardiovascular exercise 30-45 minutes, 4-5 times per week
- Omega-3 fatty acids 3-4 g EPA/DHA daily
- Citrus bergamot 500-1000 mg/day as an adjunct
Contextual consideration:
- Oxandrolone is often chosen for its relatively better lipid profile compared to stanozolol or anadrol, but the comparison is relative. It still suppresses HDL meaningfully, and users who believe "Anavar doesn't affect my cholesterol" are typically not measuring their lipids.
Further reading: Bloodwork every woman on anavar should run
Clinical Significance
Oxandrolone is frequently described as a mild oral steroid, and relative to stanozolol or oxymetholone, that characterisation is accurate. However, mild is not the same as lipid-neutral. Clinical data document HDL falling to 24 mg/dL at relatively low doses. At the doses commonly used in bodybuilding (40-80 mg/day), suppression is meaningful and warrants monitoring. The faster recovery of HDL after oxandrolone cessation compared to heavier orals is a genuine advantage, but it does not eliminate the cardiovascular risk during active use.
Frequently Asked Questions
Related Articles
When Will Orforglipron Be Available in Australia? (TGA Update)
Orforglipron (Foundayo) is not TGA approved yet; the Wegovy Pill is. Realistic Australian timeline, trial results, muscle loss and the bloodwork to run.
How Much Hair Oral Minoxidil Regrew in Phase 3 (VDPHL01 Data)
Veradermics' extended-release oral minoxidil added 22 to 30 hairs/cm² over placebo in Phase 3. What it means on TRT, with finasteride, and for your heart rate.
Does Gestrinone Work for Endometriosis? What It Does to Your Labs
Gestrinone eased endometriosis pain in small trials, but it is a 19-nor androgen. What the evidence shows, the Brazilian implant, and the labs to run.
Does Primobolan Lower Estrogen? What Users' Bloodwork Shows
Primo can't aromatize, but forums swear it lowers E2. What real user bloodwork shows, what the science says, and how to read your own labs on test and primo.
Related Pages
See how this interaction affects your blood work
Upload your blood tests and log your compounds to see personalised interaction data overlaid on your marker trends.
Quick Facts
Effect Direction
Severity
Dose-Dependent
Reversible